» Articles » PMID: 35431355

Effects of Nonsurgical Periodontal Therapy in Patients with Rheumatoid Arthritis: a Prospective Before and After Study

Overview
Date 2022 Apr 18
PMID 35431355
Authors
Affiliations
Soon will be listed here.
Abstract

Background: periodontal therapy has been suggested to have systemic effects. However, studies of periodontal therapy in rheumatoid arthritis patients have produced controversial results.

Aim: To compare the effects of nonsurgical periodontal therapy on biochemical markers of rheumatoid arthritis and periodontal parameters in patients with and without rheumatoid arthritis.

Methods: a prospective before-and-after study was conducted that included 21 participants without and 29 participants with rheumatoid arthritis. Periodontal parameters, detection, C-reactive protein, rheumatoid factor and anti-citrullinated protein antibodies were measured at baseline and three months after nonsurgical periodontal therapy and the changes were statistically assessed.

Results: In general, both groups presented statistically significant improvement in periodontal parameters (<0.05). There was an increase in the counts of in both groups at three months. In addition, there was a reduction in levels of anti-citrullinated protein antibodies and rheumatoid factor in participants with rheumatoid arthritis. In contrast, C-reactive protein levels increased in both groups but were higher in the rheumatoid arthritis group. Periodontal parameters in rheumatoid arthritis participants under disease-modifying antirheumatic drugs presented a slightly higher improvement ( <0.05).

Conclusions: Nonsurgical periodontal therapy has similar improvements in periodontal parameters in patients with and without rheumatoid arthritis. In addition, nonsurgical periodontal therapy may benefit serum levels of anti-citrullinated protein antibodies and rheumatoid factors in patients with rheumatoid arthritis. NCT04658615.

Citing Articles

The Effects of Periodontal Treatment on Rheumatoid Arthritis and of Anti-Rheumatic Drugs on Periodontitis: A Systematic Review.

Inchingolo F, Inchingolo A, Avantario P, Settanni V, Fatone M, Piras F Int J Mol Sci. 2023; 24(24).

PMID: 38139057 PMC: 10743440. DOI: 10.3390/ijms242417228.

References
1.
Papapanou P, Sanz M, Buduneli N, Dietrich T, Feres M, Fine D . Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018; 45 Suppl 20:S162-S170. DOI: 10.1111/jcpe.12946. View

2.
Kondo N, Kuroda T, Kobayashi D . Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis. Int J Mol Sci. 2021; 22(20). PMC: 8539723. DOI: 10.3390/ijms222010922. View

3.
AlMutairi K, Nossent J, Preen D, Keen H, Inderjeeth C . The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2020; 41(5):863-877. DOI: 10.1007/s00296-020-04731-0. View

4.
Socransky S, Haffajee A . Dental biofilms: difficult therapeutic targets. Periodontol 2000. 2002; 28:12-55. DOI: 10.1034/j.1600-0757.2002.280102.x. View

5.
Kaur S, Bright R, Proudman S, Bartold P . Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum. 2014; 44(2):113-22. DOI: 10.1016/j.semarthrit.2014.04.009. View